期刊文献+

Genetic association of urokinase-type plasminogen activator gene rs2227564 site polymorphism with sporadic Alzheimer's disease in the Han Chinese population

Genetic association of urokinase-type plasminogen activator gene rs2227564 site polymorphism with sporadic Alzheimer's disease in the Han Chinese population
下载PDF
导出
摘要 A missense C/T polymorphism in exon 6 (the NCBI rslD is rs2227564) of the urokinase-type plasminogen activator gene has been identified as a possible hot spot for Alzheimer's disease risk. The present study analyzed urokinase-type plasminogen gene polymorphisms of rs2227564 with sporadic Alzheimer's disease by PCR-restriction fragment length polymorphism. Results showed that CC, CT and TT genotype distribution frequencies had significant differences between sporadic Aizheimer's disease patients and healthy controls, in-depth analysis of the association between urokinase-type plasminogen gene rs2227564 polymorphisms and sporadic Alzheimer's disease indicated that people with the C-positive genotype CC + CT were at a higher risk for developing sporadic Alzheimer's disease. These results support the contribution of the polymorphisms of rs2227564 in the urokinase-type plasminogen gene to the pathogenesis of sporadicAIzheimer's disease in the Han Chinese population. A missense C/T polymorphism in exon 6 (the NCBI rslD is rs2227564) of the urokinase-type plasminogen activator gene has been identified as a possible hot spot for Alzheimer's disease risk. The present study analyzed urokinase-type plasminogen gene polymorphisms of rs2227564 with sporadic Alzheimer's disease by PCR-restriction fragment length polymorphism. Results showed that CC, CT and TT genotype distribution frequencies had significant differences between sporadic Aizheimer's disease patients and healthy controls, in-depth analysis of the association between urokinase-type plasminogen gene rs2227564 polymorphisms and sporadic Alzheimer's disease indicated that people with the C-positive genotype CC + CT were at a higher risk for developing sporadic Alzheimer's disease. These results support the contribution of the polymorphisms of rs2227564 in the urokinase-type plasminogen gene to the pathogenesis of sporadicAIzheimer's disease in the Han Chinese population.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第30期2377-2383,共7页 中国神经再生研究(英文版)
基金 supported by the National Natural Science Foundation of China, No. 30470615
关键词 Alzheimer's disease urokinase plasminogen activator POLYMORPHISM genetic testing Han Chinesepopulation neural regeneration Alzheimer's disease urokinase plasminogen activator polymorphism genetic testing Han Chinesepopulation neural regeneration
  • 相关文献

参考文献43

  • 1Seripa D, Panza F, Franceschi M, et al. Non-apolipoprotein E and apolipoprotein E genetics of sporadicAIzheimer's disease. Ageing Res Rev. 2009; 8(3):214-236.
  • 2Evans DA, Beckett LA, Field TS, et al. Apolipoprotein E epsilon 4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997; 277(10):822-824.
  • 3SlooterAJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol. 1998;55(7):964-968.
  • 4Selkoe D J, Podlisny MB. Deciphering the genetic basis of Alzheimer's disease. Annu Rev Genomics Hum Genet. 2002;3:67-99.
  • 5Ertekin-Taner, Ronald J, Feuk L, et al. Elevated amyloid beta protein (Abeta42) and late onset AIzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Human Molecular Genetics. 2005; 14(3): 447-460.
  • 6Finckh U, van Hadeln K, Muller-Thomsen T, et al. Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2. Neurogenetics. 2003;4(4):213-217.
  • 7Ozturk A, Minster RL, DeKosky ST, et al. Association of tag SNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits. Am J Med Genet B Neuropsychiatr Genet. 2007;144(1 ):79-82.
  • 8Pesaresi M, Batelli S, Prato F, et al. The urokinase-type plasminogen activator polymorphism PLAU_I is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta (1-42)level. Neurobiol Dis. 2007;25(3): 609-613.
  • 9Riemenschneider M, Konta L, Friedrich P, et al. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease Hum Mol Genet. 2006;15(16):2446-2456,.
  • 10Thornton-WeUs TA, Moore JH, Martin ER, et al Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis. Genet Epidemiol. 2008;32(3) 187-203.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部